164 related articles for article (PubMed ID: 37823932)
1. The fluctuations of expression profiles of critical genes in the miRNA maturation process and pro-and anti-inflammatory cytokines in the pathogenesis and progression of multiple sclerosis.
Khakdan F; Javanmard AS; Shahmoradipour P; Jahromi MJ
Mol Biol Rep; 2023 Nov; 50(11):9405-9416. PubMed ID: 37823932
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients.
Jafari N; Shaghaghi H; Mahmoodi D; Shirzad Z; Alibeiki F; Bohlooli S; Dogaheh HP
J Clin Neurosci; 2015 Jan; 22(1):200-3. PubMed ID: 25439752
[TBL] [Abstract][Full Text] [Related]
3. Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases.
Nali LH; Olival GS; Sousa FTG; de Oliveira ACS; Montenegro H; da Silva IT; Dias-Neto E; Naya H; Spangenberg L; Penalva-de-Oliveira AC; Romano CM
Mult Scler Relat Disord; 2020 Sep; 44():102243. PubMed ID: 32559700
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis.
Fattahi M; Rezaei N; Nematalahi FS; Shaygannejad V; Fouladi S; Karimi L; Fathi F; Dehghani L; Mirmosayyeb O; Eskandari N
Mult Scler Relat Disord; 2019 Oct; 35():241-245. PubMed ID: 31421628
[TBL] [Abstract][Full Text] [Related]
5. Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients.
D'Angelo C; Reale M; Costantini E; Di Nicola M; Porfilio I; de Andrés C; Fernández-Paredes L; Sánchez-Ramón S; Pasquali L
Front Immunol; 2018; 9():1240. PubMed ID: 29915590
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
7. Monocyte-derived cytokines in multiple sclerosis.
Filion LG; Graziani-Bowering G; Matusevicius D; Freedman MS
Clin Exp Immunol; 2003 Feb; 131(2):324-34. PubMed ID: 12562396
[TBL] [Abstract][Full Text] [Related]
8. A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis.
Pasquali L; Lucchesi C; Pecori C; Metelli MR; Pellegrini S; Iudice A; Bonuccelli U
J Neuroimmunol; 2015 Jan; 278():53-9. PubMed ID: 25595252
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 SNP
Bruno A; Dolcetti E; Azzolini F; Moscatelli A; Gambardella S; Ferese R; Rizzo FR; Gilio L; Iezzi E; Galifi G; Borrelli A; Buttari F; Furlan R; Finardi A; De Vito F; Musella A; Guadalupi L; Mandolesi G; Centonze D; Stampanoni Bassi M
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627281
[No Abstract] [Full Text] [Related]
10. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis.
Sánchez-López AL; Ortiz GG; Pacheco-Moises FP; Mireles-Ramírez MA; Bitzer-Quintero OK; Delgado-Lara DLC; Ramírez-Jirano LJ; Velázquez-Brizuela IE
Arch Med Res; 2018 Aug; 49(6):391-398. PubMed ID: 30595364
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
[TBL] [Abstract][Full Text] [Related]
13. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
[No Abstract] [Full Text] [Related]
14. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.
Keller A; Leidinger P; Lange J; Borries A; Schroers H; Scheffler M; Lenhof HP; Ruprecht K; Meese E
PLoS One; 2009 Oct; 4(10):e7440. PubMed ID: 19823682
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression.
Mancuso R; Hernis A; Agostini S; Rovaris M; Caputo D; Clerici M
J Transl Med; 2015 May; 13():148. PubMed ID: 25947625
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
[TBL] [Abstract][Full Text] [Related]
18. Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β.
De Felice B; Mondola P; Sasso A; Orefice G; Bresciamorra V; Vacca G; Biffali E; Borra M; Pannone R
BMC Med Genomics; 2014 May; 7():26. PubMed ID: 24885345
[TBL] [Abstract][Full Text] [Related]
19. MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.
Zanghì A; Manuti V; Serviddio G; D'Amico E; Avolio C
Front Immunol; 2023; 14():1226130. PubMed ID: 37711630
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
